SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mod who wrote (5974)1/27/1999 2:00:00 AM
From: jake burns  Read Replies (1) of 6136
 
It seems as if AGPH's enemy is TIME. In the back of my head, I'm thinking perhaps AGPH is afraid of new drugs coming on the scene that might make Viracept irrelevant (Hollis Eden's drug, Inactivin, perhaps....HEPH has run from 12 to 25 off no news...maybe something's up there.)....Seems as if they went a long way to frustrate hostile takeover attempts....Does anyone seriously believe this is the best offer they could get. I don't for a minute. But I don't mean to imply I hate the deal. Actually, I like the fact it's a stock deal, and WLA will be a good partner...we have much less risk now....But is this the best deal? No. Thoughts, anyone?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext